Not Medicare Enrolled

Dr. Marco Renazco, M.D.

Psychiatry · Katy, TX
707 S FRY RD, Katy, TX 77450
2815993313
Registered in NPPES since 2006
NPI: 1518038751 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Renazco from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Renazco? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Renazco

Dr. Marco Renazco is a psychiatry specialist in Katy, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Renazco received a total of $36,198 from 38 pharmaceutical and/or device companies across 382 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Renazco is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $36,198 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$36,198
Total received (2018-2024)
Avg $5,171/year across 7 years
Top 4% in TX for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
382
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,114
2023
$1,410
2022
$3,227
2021
$3,598
2020
$10,802
2019
$9,058
2018
$6,990

Payments by company (2024)

ABBVIE INC.
$183
Otsuka America Pharmaceutical, Inc.
$162
Vanda Pharmaceuticals Inc.
$145
Corium, LLC
$100
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$84
Lundbeck LLC
$75
Tempus AI, Inc
$70
Takeda Pharmaceuticals U.S.A., Inc.
$59
Bausch Health US, LLC
$53
Supernus Pharmaceuticals, Inc.
$44
Almatica Pharma LLC
$31
Brainsway USA INC
$25
Noven Therapeutics, LLC
$17
Tris Pharma Inc
$17
Vertical Pharmaceuticals, LLC
$17
IDORSIA PHARMACEUTICALS US INC
$16
Neos Therapeutics, LP
$16
Top 3 companies account for 44.0% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan Inc.
$11,934
Allergan, Inc.
$11,800
Janssen Pharmaceuticals, Inc
$2,651
ABBVIE INC.
$2,556
AbbVie Inc.
$1,406
US WorldMeds, LLC
$768
Takeda Pharmaceuticals U.S.A., Inc.
$606
Vanda Pharmaceuticals Inc.
$577
Otsuka America Pharmaceutical, Inc.
$469
Lundbeck LLC
$407
Corium, LLC
$387
Bausch Health US, LLC
$370
ITI, Inc.
$304
Supernus Pharmaceuticals, Inc.
$223
Neos Therapeutics, LP
$205
Teva Pharmaceuticals USA, Inc.
$178
Ironshore Pharmaceuticals Inc.
$127
Axsome Therapeutics, Inc.
$107
IDORSIA PHARMACEUTICALS US INC
$107
Shire North American Group Inc
$104
Noven Therapeutics, LLC
$103
Eisai Inc.
$102
Indivior Inc.
$96
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$84
Alkermes, Inc.
$76
Tempus AI, Inc
$70
JAZZ PHARMACEUTICALS INC.
$69
Almatica Pharma LLC
$48
Adlon Therapeutics L.P.
$42
Vertical Pharmaceuticals, LLC
$38
Avanir Pharmaceuticals, Inc.
$34
Neuronetics, Inc.
$27
EISAI INC.
$25
Brainsway USA INC
$25
Neurocrine Biosciences, Inc.
$19
Orexo US, Inc.
$19
Tris Pharma Inc
$17
Otsuka Pharmaceutical Development & Commercialization, Inc.
$17
Top 3 companies account for 72.9% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Auvelity · Azstarys · BRINTELLIX · Brainsway Deep TMS System · CAPLYTA · Cotempla XR-ODT · Dayvigo · Dyanavel XR · FANAPT · Fanapt · HETLIOZ · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LOREEV XR · Lucemyra/Lofexidine · METHYLPHENIDATE 72 · MYDAYIS · NEUROSTAR TMS THERAPY · NUEDEXTA · PERSERIS · QELBREE · QUVIVIQ · Qelbree · REXULTI · Relexxii · SECUADO · SPRAVATO · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SUNOSI · Secuado · TRINTELLIX · Tempus Pixel · Trintellix · VRAYLAR · VYVANSE · WELLBUTRIN · Xelstrym · Zubsolv
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a psychiatry specialist in Katy?
Compare psychiatrists in the Katy area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists in nearby ZIP areas
716
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
OCEANS BEHAVIORAL HOSPITAL OF KATY
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Renazco is a psychiatry specialist, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Renazco receive payments from pharmaceutical companies?
Yes. Dr. Renazco received a total of $36,198 from 38 companies across 382 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Renazco) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Psychiatrists in Katy
Browse psychiatrists in Katy ranked by procedure volume and transparency data.
Highest volume
Top Psychiatrists in TX
Psychiatrists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Psychiatrists in TX
Which TX psychiatrists receive the most from drug and device companies.
By company
Allergan Inc. Payments to Doctors
See all physicians who received payments from Allergan Inc.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →